(Q41153289)

27 September 2017

title

Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

multicenter clinical trial

6 December 2022

main subject

0 references

author name string

O. A. Nielsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835251

6 December 2022

I. Morsing

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835251

6 December 2022

J. S. Petersen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835251

6 December 2022

T. Larsen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835251

6 December 2022

S. E. Møller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835251

6 December 2022

P. M. Manniche

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835251

6 December 2022

O. B. Skausig

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835251

6 December 2022

language of work or name

English

0 references

publication date

1 September 1991

1 reference

full work available at URL

27 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1991.tb03136.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1991.tb03136.x/fullpdf

6 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

Acta Psychiatrica Scandinavica

6 December 2022

published in

1 reference

27 September 2017

volume

84

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

233-241

1 reference

Duration of antidepressant drug treatment. What is an adequate trial?

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1991.TB03136.X

Continuation drug therapy for major depressive episodes: how long should it be maintained?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1991.TB03136.X

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1991.TB03136.X

Quantitative determination of branched-chain and aromatic amino acids by ion-exchange chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1991.TB03136.X

Plasma levels and antidepressive effect of imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1991.TB03136.X

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

Paroxetine in the treatment of depression--a randomized comparison with amitriptyline

6 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin

6 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

An interim overview of the safety and tolerability of paroxetine

6 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

An evaluation of continuation therapy with tricyclic antidepressants in depressive illness

6 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

Study duration in antidepressant research: advantages of a 12-week trial

6 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

THE DIAGNOSIS OF DEPRESSIVE SYNDROMES AND THE PREDICTION OF E.C.T. RESPONSE.

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

The WHO Depression Scale. Relationship to the Newcastle Scales

6 December 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

Quantitative rating of depressive states

6 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

6 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection

6 December 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

Imipramine metabolites in blood of patients during therapy and after overdose

6 December 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

Imipramine: Clinical effects and pharmacokinetic variability

6 December 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

Plasma ratio tryptophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression

6 December 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

Biochemical and diagnostic classification and serum drug levels: relation to antidepressive effect of imipramine

6 December 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03136.X

6 December 2022

Identifiers

1 reference

27 September 2017

1 reference